Canadian Pacific Kansas City Limited (CP)

Ligand Pharmaceuticals Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	799	739	464	451	69	147
Cash & Short-Term Investments	799	739	464	451	69	147
Cash Growth	43.45%	59.27%	2.88%	553.62%	-53.06%	10.53%
Accounts Receivable	2,005	1,560	1,496	758	594	637
Other Receivables	-	408	391	258	225	188
Receivables	2,005	1,968	1,887	1,016	819	825
Inventory	455	457	400	284	235	208
Restricted Cash	-	-	-	-	13	-
Other Current Assets	266	220	251	138	216	141
Total Current Assets	3,525	3,384	3,002	1,889	1,352	1,321
Property, Plant & Equipment	54,458	56,388	52,091	22,652	21,487	20,422
Long-Term Investments	454	586	533	45,314	42,518	199
Goodwill	18,352	19,350	17,729	344	328	329
Other Intangible Assets	2,940	3,146	2,974	42	43	353
Other Long-Term Assets	5,451	4,890	3,573	3,254	2,449	1,016
Total Assets	85,180	87,744	79,902	73,495	68,177	23,640
Accounts Payable	2,736	768	680	503	432	401
Accrued Expenses	-	1,207	1,093	652	678	685
Current Portion of Long-Term Debt	1,042	2,805	3,129	1,502	1,446	1,178
Current Portion of Leases	-	126	116	76	163	71
Current Income Taxes Payable	-	379	255	177	164	115
Current Unearned Revenue	-	-	-	-	-	27
Other Current Liabilities	-	376	437	303	276	176
Total Current Liabilities	3,778	5,661	5,710	3,213	3,159	2,653
Long-Term Debt	21,227	19,783	19,320	18,111	18,541	8,450
Long-Term Leases	-	275	273	232	260	383
Long-Term Unearned Revenue	-	87	84	54	61	39
Long-Term Deferred Tax Liabilities	11,608	11,974	11,052	12,197	11,352	3,666
Other Long-Term Liabilities	875	526	471	264	257	298
Total Liabilities	38,033	38,854	37,491	34,609	34,348	16,321
Common Stock	25,285	25,689	25,602	25,516	25,475	1,983
Additional Paid-In Capital	105	94	88	78	66	55
Retained Earnings	19,863	19,429	16,420	13,201	10,391	8,095
Comprehensive Income & Other	951	2,680	-618	91	-2,103	-2,814
Total Common Equity	46,204	47,892	41,492	38,886	33,829	7,319
Minority Interest	943	998	919	-	-	-
Shareholders' Equity	47,147	48,890	42,411	38,886	33,829	7,319
Total Liabilities & Equity	85,180	87,744	79,902	73,495	68,177	23,640
Total Debt	22,269	22,989	22,838	19,921	20,410	10,082
Net Cash (Debt)	-21,470	-22,250	-22,374	-19,470	-20,341	-9,935
Net Cash Per Share	-23.03	-23.81	-23.96	-20.87	-29.79	-14.61
Filing Date Shares Outstanding	917.98	933.71	932.43	930.77	929.71	666.49
Total Common Shares Outstanding	917.9	933.5	932.1	930.5	929.7	666.5
Working Capital	-253	-2,277	-2,708	-1,324	-1,807	-1,332
Book Value Per Share	50.34	51.30	44.51	41.79	36.39	10.98
Tangible Book Value	24,912	25,396	20,789	38,500	33,458	6,637
Tangible Book Value Per Share	27.14	27.21	22.30	41.38	35.99	9.96
Land	-	5,700	5,266	964	-	-
Buildings	-	1,927	1,732	1,069	1,022	937
Machinery	-	8,537	7,943	4,915	4,502	4,400

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q